Rapid Microbiology Testing Market worth $8.3 billion by 2029
The report "Rapid Microbiology Testing Market by Product (Instruments (Automated Identification System, PCR, Mass Spectrometer) Reagent, Kits), Method (Growth, Nucleic Acid, Viability), Application (Clinical Diagnosis, Industrial, Research) - Global Forecast to 2029", is valued at an estimated USD 5.2 billion in 2024 and is projected to reach USD 8.3 billion by 2029 at a CAGR of 10.1% during the forecast period.
Browse 318 market data Tables and 45 Figures spread through 331 Pages and in-depth TOC on "Rapid Microbiology Testing Market by Product (Instruments (Automated Identification System, PCR, Mass Spectrometer) Reagent, Kits), Method (Growth, Nucleic Acid, Viability), Application (Clinical Diagnosis, Industrial, Research) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/rapid-microbiology-testing-market-31548521.html
In 2023, the instruments segment held the largest share of the rapid microbiology testing market by product segment.
Based on product, the rapid microbiology testing market has been segmented into instruments, reagents & kits and consumables. The instruments segment dominated the rapid microbiology testing market in 2023. The large share of this segment can be attributed to the ongoing trend of laboratory automation among clinical laboratories.
The industrial testing segment held the largest share of the rapid microbiology testing market by application segment in 2023.
Based on applications, the rapid microbiology testing market is segmented into clinical disease diagnosis, industrial testing, and research applications. In 2023, the largest share of the rapid microbiology testing market was held by the industrial testing segment. This is primarily due to the extensive use of rapid microbiology testing methods in industries such as pharmaceuticals, food and beverage, cosmetics, and environmental monitoring. In these industries, ensuring product quality, safety, and compliance with regulatory standards is of utmost importance. Rapid microbiology testing allows for quick detection and identification of microbial contaminants, facilitating timely corrective actions and minimizing production downtime.
North America is the largest regional market for rapid microbiology testing market.
The market for rapid microbiology testing has been divided into six key geographical regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. In 2023, North America held the predominant portion of the rapid microbiology testing market. The high adoption of advanced diagnostic technologies in North America is driving market growth in this regional segment. This trend is further fueled by the rising awareness among healthcare professionals and the general population about the importance of early detection and prompt treatment. The strong focus on healthcare infrastructure and the increasing healthcare expenditure in North America also contribute to market growth, as do the expanding pharmaceutical and biotechnology industries. The food safety sector is another significant contributor, with rapid microbiology testing integral to ensuring the safety and quality of the food supply chain.
The major players operating in this market are bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Sartorius AG (Germany), Bruker (US), QuidelOrtho Corporation (US), Charles River Laboratories (US), Neogen Corporation (US), Don Whitley Scientific Limited (UK), Rapid Micro Biosystems, Inc. (US), Gradientech (Sweden), rqmicro AG (Switzerland), Colifast AS (Norway), Serosep Limited (Ireland), Solus PerkinElmer (US), BTNX Inc. (Canada), R-Biopharm AG (Germany), Paragon Genomics, Inc. (US), Kypha Inc. (US), Vivione Biosciences (US), Bactest Ltd. (UK), and CorDx (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Rapid Microbiology Testing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
